#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14644	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2037	710.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1395	1395	C	896	C,T	838,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14644	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2037	710.4	0	HET	.	.	.	C451T	.	451	451	C	662	662	C	814	C,T	400,368	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26182	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3581	728.1	0	.	n	.	0	T695C	SNP	695	695	T	1023	1023	C	801	C	747	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26182	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3581	728.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2299	2299	C	801	C	726	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26182	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3581	728.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2373	2373	A	828	A	789	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26182	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3581	728.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2925	2925	C	819	C,A	767,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2092	folP	855	855	100.0	folP.l6.c30.ctg.1	1747	119.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1110	1112	AGC	219;218;219	A;G;C,T,A	206;206;204,1,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5204	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3450	150.2	1	SNP	p	S91F	1	.	.	271	273	TTC	652	654	TTC	174;174;176	T;T;C	160;160;158	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5204	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3450	150.2	1	SNP	p	D95G	1	.	.	283	285	GGC	664	666	GGC	187;189;190	G;G;C,G	165;170;168,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5204	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3450	150.2	1	SNP	p	G95N	0	.	.	283	285	GGC	664	666	GGC	187;189;190	G;G;C,G	165;170;168,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1660	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1419	116.5	0	.	p	.	0	A39T	NONSYN	115	117	GCC	524	526	ACC	190;189;185	A;C;C	174;180;175	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1660	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1419	116.5	0	.	p	.	0	R44H	NONSYN	130	132	CGC	539	541	CAC	176;177;179	C;A;C	168;167;171	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1660	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1419	116.5	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	722	724	CAC	202;202;203	C;A;C	190;187;192	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1660	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1419	116.5	1	SNP	p	G45D	0	.	.	133	135	GGC	542	544	GGC	179;179;181	G;G;C	170;165;173	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	984	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1103	89.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5172	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2957	174.0	1	SNP	p	D86N	0	.	.	256	258	GAC	569	571	GAC	202;204;204	G;A;C	183;179;186	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5172	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2957	174.0	1	SNP	p	R87I	0	.	.	259	261	CGT	572	574	CGT	202;202;200	C;G;T	184;185;180	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5172	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2957	174.0	1	SNP	p	R87W	0	.	.	259	261	CGT	572	574	CGT	202;202;200	C;G;T	184;185;180	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5172	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2957	174.0	1	SNP	p	S87R	1	.	.	259	261	CGT	572	574	CGT	202;202;200	C;G;T	184;185;180	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5172	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2957	174.0	1	SNP	p	S88P	0	.	.	262	264	TCC	575	577	TCC	202;200;199	T;C;C	180;180;179	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4538	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2587	174.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1486	1488	GGC	234;232;227	G;G;C	213;212;207	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	171.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1204	1206	GCC	202;203;203	G;C;C	188;190;190	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	171.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1207	1209	ATG	203;204;206	A;T;G	190;190;189	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	171.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1219	1221	ACC	199;202;201	A;C;C,T	184;185;180,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	171.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1219	1221	ACC	199;202;201	A;C;C,T	184;185;180,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	171.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1720	1722	ACC	227;224;226	A;C;C	201;207;209	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	171.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1774	1776	GCG	245;249;246	G;C,G;G	228;227,1;226	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	171.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1774	1776	GCG	245;249;246	G;C,G;G	228;227,1;226	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	171.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1897	1899	GGT	169;168;162	G;G;T	160;155;154	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	171.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1906	1908	AGC	148;148;151	A,G;G;C	142,1;142;145	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4002	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2314	171.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1924	1926	CCG	140;141;144	C,G;C;G	114,4;114;120	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5766	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3169	181.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1707	1709	CCG	191;190;190	C;C;G	173;174;171	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2360	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1598	145.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	507	507	C	179	C	166	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	319	90.43	porB1a.l15.c30.ctg.2	546	19.1	0	.	p	.	0	H217N	NONSYN	649	651	CAT	250	252	AAT	11;12;12	A;A;T	11;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	319	90.43	porB1a.l15.c30.ctg.2	546	19.1	0	.	p	.	0	D218N	NONSYN	652	654	GAT	253	255	AAT	12;12;12	A;A;T	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	319	90.43	porB1a.l15.c30.ctg.2	546	19.1	0	.	p	.	0	V226A	NONSYN	676	678	GTA	277	279	GCA	16;17;17	G;C;A	16;16;17	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	319	90.43	porB1a.l15.c30.ctg.2	546	19.1	0	.	p	.	0	.	MULTIPLE	700	702	ACT	300	302	GTA	20;20;19	G;T;A	20;18;19	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	278	porB1a	984	319	90.43	porB1a.l15.c30.ctg.2	546	19.1	0	.	p	.	0	N237fs	FSHIFT	709	709	A	309	309	A	18	A	18	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2908	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1457	197.7	0	.	p	.	0	G210R	NONSYN	628	630	GGA	905	907	AGA	230;228;228	A;G;A	214;211;212	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2908	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1457	197.7	0	.	p	.	0	S217G	NONSYN	649	651	AGT	926	928	GGT	241;242;245	G;G;T	226;227;230	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2908	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1457	197.7	1	SNP	p	G120K	1	.	.	358	360	AAG	635	637	AAG	234;234;234	A;A;G	219;219;216	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2908	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1457	197.7	1	SNP	p	N121D	0	.	.	361	363	AAC	638	640	AAC	232;229;229	A;A;C	215;212;214	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2908	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1457	197.7	1	SNP	p	A121N	1	.	.	361	363	AAC	638	640	AAC	232;229;229	A;A;C	215;212;214	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9940	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4863	203.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1176	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1088	107.4	1	SNP	p	V57M	1	.	.	169	171	ATG	496	498	ATG	251;254;252	A;T;G	228;231;228	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
